IPOs

The Aspen IPO provides an opportunity to benefit from the specialty market without commensurate prior-year reserve risks due to an LPT cover.

Insurance Insider US dissects the largest and hottest deals of the year across broking, reinsurance and other segments of the industry.

The company also confirmed earlier reports from this publication that Goldman Sachs would be a leading bookrunner, along with Citigroup, Jefferies and Apollo Global Securities for its ~$4bn H1 2024 IPO in New York.

Sources said that the New York-based underwriter lined up JP Morgan and Morgan Stanley as lead bookrunners for the process.

The CEO emphasized that while trading conditions are favorable for the specialty segment, the company would make the decision to go public based on its own merit rather than market timing.

The announcement comes almost two months after this publication revealed that the carrier had lined up Goldman Sachs, Citibank and Jefferies to run its $4bn H1 IPO in New York.

As this publication previously reported, the IPO pricing came in under book value but has still narrowed the gap on predecessor Fidelis, listing at 0.9x book value vs Fidelis’ 0.8x.

Inside P&C’s morning summary of the key stories to get you up to speed fast.

Hamilton’s IPO share price came in at the lower end of historical trends observed amongst insurers that have missed their target range upon listing.

Inside P&C’s morning summary of the key stories to get you up to speed fast.

The carrier’s $15 per share listing came in below its $16.90 book value per share at the mid-year reporting point, or a 0.9x multiple.

The carrier is offering 15 million Class B common shares, according to a registration statement filed with the SEC.